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years arrive. T1�e child bearing 
years are past. h,r most women it 
is a difficult time. Hormonal and 
other physiologic systems undergo 
major alteration. These changes 
exact from the emotional make-up 
of each woman equal measures of 
adjustment and alteration. The 
process of reproductive involution 
stirs anew the serious deliberations 
about a woman's role, responsibility 
and purpose in life. The anxieties 
of youthful menarche are revisited, 
but the mystery and challenge of 
fertility is not the problem. Instead 
there is apprehension and reluctance 
over the changes leading to infer­
tility. For the woman who has tam­
pered with these natural functions 
and aborted, there is so often an 
extra burden. For there arises from 
the realm of repressed conflicts the 
haunting reminder of the dreadful 
�ct. When the miracle and priv­
ilege of procreation is denied by 
involution, she is forced to retrace 
old unsettled feelings. One sees 
348 
unusual amounts of guilt, SE 
ment and despondency. 
These are but a few obs, 
gathered from the histories 
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pie outside the· courts. Ct· 
is not placed upon them b 
Yet it is felt. For in the mir 
is always held. The verdict 
and the sentence harsh. r, 
sentenced to hear a noise 
and tormenting . It is an � 
the quiet murder. 
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Regulation of Ovulation Time In 
Normal Women With Clomiphene Citrate· 
and Perfecting the Practice 
of the Rhythm Method· 
J. G. BouTSELIS, M.D., N. VoRYS, M.D. AND J.C. ULLERY, M.D. 
According to Marshall, the basic 
fundamentals of the rhythm method 
have been known to physicians for 
the past 35 years; however, this 
form of family planning has failed 
to obtain the confidence of a sig­
nificant segment of the Catholic 
population. Even highly motivated 
and properly instructed patients fre­
quently fail to accomplish their ob­
jective because of an unsuspected 
premature or late ovulation in an 
otherwise fairly predic:table ovula­
tory pattern. These rhythm failures 
would imply th.at the responsible 
body processes which regulate the 
time of ovulation are not perfect 
and possess intrinsic peculiarities 
which prohibit repeated perfect tim­
ing of ovulation. Hypothalamic dis­
turbance is but one example of how 
the pituitary-ovarian axis might dis­
turb ovulation timing. 
During the past decade, many 
steroid compounds have been made 
available for use in the area of 
family planning and their efficacy 
has been virtually 100 per cent. 
Their mode of action is attributed 
lo a three-fold mechanism, namely: 
0) Inhibition of ovulation, (2) 
roduction of a hostile cervical
ucus, and (3) interfering with
plantation of a fertilized egg by
tering the endometrial environ­
t.1·2·5·10,12 It is not within the
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scope of this presentation to discuss 
the morality of their use. 
The purpose of this report is to 
discuss our experience with clo­
miphene citrate and  its ability 
to regulate the time of ovulation. 
Clomiphene is a n e w  orally. 
administered non-steroid compound 
which is an analogue of the weak 
estrogen TACE. Clomiphene was 
made available in 1960 for infertile 
anovulatory patients. When admin­
istered to these patients, ovulation 
occurred and is characterized by all 
scientific criteria of ovulation, in­
cluding pregnancy. In a summa­
rized report by Johnson et al/ it was 
noted that 1809 out of 2616 anovu­
latory patients ovulated following 
the administration: of clomiphene 
citrate and approximately 40 per 
cent became pregnant during the 
first three clomiphene treated cycles. 
The mechanism of action of clomi­
phene is by the direct stimulation 
of the ovary11 or by the stimulation 
of the hypothalamico pituitary axis.3 
In a careful review of the litera­
ture, there are no published reports 
concerning the use of clomiphene 
citrate in normal women for . the 
regulation of ovulation time. The 
purpose of this study was to see if 
clomiphene citrate would regulate 
the time of ovulation and make the 
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practice of the rhytnm method more 
effective. 
MATERIAL AND METHODS 
The 96 normal patients partici­
pating in this study were a group 
of highly motivated patients wishing 
to space or limit the number of 
children in their families by the use 
of the rhythm method. Their ages 
varied between 20 and 40 years of 
age with an average parity of four. 
Before a d m i tted to the s tu dy, 
each patient presented documented 
evidence of six months of basal body 
temperature graphs. The adminis­
tered dose of clomiphene citrate was 
50 mgs. daily for 5 days beginning 
on the fifth day of the menstrual 
cycle. Basal  body tern pera  ture  
graphs were maintained by each 
patient while on clomid therapy. 
Patients were seen in the office each 
month for pelvic examination, cervi­
cal mucus study, B.B.T. graph 
review, vaginal cytology and, in 
selected cases, endometrial biopsy 
for histologic and histochemical an­
alysis. This phase of the study was 
considered important to assure that 
no adverse changes occurred at or 
following ovulation which might 
interfere with the normal physio­
logic events leading to conception 
and implantation. One might con­
clude that these precautions were 
unnecessary, since previous docu­
mented studies4 dealing with 2616 
anovulatory patients treated with 
clomiphene citrate responded favor­
ably with ovulation and pregnancy. 
RESULTS 
Utilizing basal body temperature 
as an indicator of ovulation, com­
parisons were made of the patients' 
ovulato r y  p a tterns before  a n d  
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during clomiphene citrate 
Since the phrase "variati01 
lation" is repeatedly used 
out this study, an explar 
this phrase may be neces 
instance, during the 6-mont 
period of B.B.T. recording ( 
the 6 months of clomid tl 
a patient ovulated betwee 
and 16 of her cycles, ther 
tient had a variation of ov1 
three days. Therefore, the 
this phase of our study 
reported as follows: 
I. During clomiphene 
ovulation was controlled 
days in 94 patients (97.S 
pared to 24 patients (25� 
the control period. 
2. During clomiphenc 
ovulation time was control 
2 days in 89 patients (92.· 
pared to 18 patients (19� 
the control period. 
�rapy. 
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3. In general, 95 out , f 96 pa­
tients exhibited a signilh�ant im­
provement in their ovulate, y pattern 
while on clomiphene ther,ipy. With 
one exception, no prematme or late 
ovulations occurred in patients 
under clomiphene therapy. 
Viewing these results from a 
slightly different perspective, it was 
important to note when ovulation 
occurred following the last admin­
istered dose of clomiphcne citrate. 
The overwhelming majority of ovu­
lations (90%) occurred 6-8 days 
after the last dose of clomiphene 
citrate. 
If the normal corpus lutein pha�e 
of the menstrual cycle is approxi­
mately 14 days, then clomiphene 
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treated patients exhibited a corpus 
lutein phase of nearly IS days. This 
is indirect evidence that clomiphene 
stimulates, rather than suppresses, 
pituitary gonadotropic secretions. 
The menstrual cycle length under 
clomid therapy exhibited excellent 
regularity with an overall increase 
in the cycle length of nearly 2 days. 
The character of the menses were 
normal in all but 5 patients. The 
latter reported heavier periods when 
compar e d  to t heir pre-c lomid  
therapy menses. 
Side reactions to clomiphene ther­
apy included ovulatory pain (8), 
hot flashes ( 4), questionable hair 
loss (2), weight gain (I), itching 
(I), blurry vision (I), and moderate 
ovarian enlargement (3). All side 
reactions were considered mild and 
transient by the patients  and 
investigators. 
Studies on cervical mucus, vaginal 
cytology, and on endometrial biop­
sies were normal. Exhaustive labo­
ratory studies have been documented 
by previous competent investigators 
in tr eating 2616 anovu l a tory 
patients with clomiphene citrate.4 
These studies were designed to eval­
uate the pituitary, adrenals, thyroid, 
liver, blood and other body systems. 
No adverse functions to clomid ther­
apy were encountered. 
CONCLUSIONS 
Out of 96 normal patients par­
ticipating in this preliminary study, 
all but one exhibited a beneficial 
ect in regulating menstrual cycle 
length and ovulation time. 
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ovu-
6 to 8 days after 
the last administered dose of clomi­
phene. It should be emphasized 
that clomiphene does not induce a 
stereotype response of ovulation 
time in all patients. Though varia­
tions in ovulatory response exist 
between patients, each patient re­
sponds rather consistently during 
clomid therapy. Therefore, each pa­
tient should be managed individu­
ally and not on a collective basis 
in determining their fertile and 
infertile periods. 
The sequence of events concerned 
with fertilization and implantation 
are not affected adversely by clomi­
phene citrate therapy. This con­
clusion is based on the present 
observations and documented reports 
by previous investigators. 
It should be emphasized that 
clomiphene citrate stimulates the 
processes concerned with ovulation 
rather than suppresses ovulation. 
It is the au_thors' opinion that 
clomiphene citrate is a useful agent 
in regulating ovulation time and 
perfecting the practice of the rhythm 
method. More important than at­
tempting to predict and pinpoint 
ovulation time is the ability of clo­
miphene citrate to prevent unex­
pected premature or late ovulations. 
It is hoped that further studies with 
clomiphene citrate will suggest that 
patients practicing the rhythm 
method of family planning may 
discontinue the tedious task of B.B.T. 
recording while they remain on 
stabilized clomid therapy. 
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An Intellectual Spiritual Week-End 
PHILIP C. ROND, M.D. AND EDWARD R. SCHUMACHER, M.D . 
In place of a yearly retreat, at the 
Diocesan Retreat House, the Guild 
of Catholic Physicians held an Intel­
lectual Spiritual Week-End at one 
of the more quiet, modern motels 
in the Columbus, Ohio area. The 
resulting spiritual uplift was highly 
rewarding. An enthusiasm was gen­
erated we have never seen in a 
retreat. 
During the planning and discus­
sion phase, in the winter months 
(it was held in April, 1966), there 
wa·s a good exchange of ideas on 
pros and cons of substituting this 
type of week-end for the annual 
retreat. It seems in retrospect that 
it was the institutionalists versus 
the prophetists. Father Murchland 
points out "there are two such 
inevitable di�ensions to any reli­
gious or moral positiop." 
Since institutional thinkers tend 
to conform to current patterns, these 
wanted an accepted routinized re­
treat. The prophetic minds were for 
reform and change. They wanted a 
new type of experience. They wanted 
to generate a Western religious cul­
tural reform, rather than conform 
to the old norms. Again, we say, 
this was done without conscious 
awareness, without being aware, as 
Murchland points out, that the 
prophetic "argues for a serious revi­
sion of thought away from purely 
juridical modes of thinking, towards 
rnodes of thinking that better reveal 
the spiritual and ethical substance 
of our tradition. The prophetic is 
grounded in the priesthood of all 
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the faithful and is historical. It is 
essentially dynamic and incentive." 
The week-end as it finally devel­
oped was held at a modern motel, 
in a section that provided an attrac­
tive meeting room, and a high 
degree of privacy. It was attended 
by Catholic . physicians and their 
wives. Non-Catholic physicians and 
other Catholic non-medical scientists 
were interested in part1c1pating; 
however, because it was the first 
venture in a new endeavor, they 
were not included. In the future it 
would seem advisable to expand the 
registration to include them. 
The participants registered in Fri­
day evening at 7 p.m., remained 
through Saturday, and checked out 
Sunday at noon. All meals were 
served on the premises. The only 
trip away from the meeting place 
was for Sunday Mass. 
The week-end was a crowded 
one, with the emphasis on talking 
rather than silence. I t  was not just 
a matter of listening to the spiritual 
leader, in this case Father William 
McNamara of the Spiritual Life In­
stitute, Sedona, Arizona, but rather 
a matter of listening to and exchang­
ing of ideas. Father McNamara 
shared the speakers table with three 
of the physicians who presented 
topics for discussion. 
The conferences, seven in number, 
were held in a round table fashion. 
After each conference topic had 
been presented there followed group 
discussion which always had to be 
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